Back to catalogue
№ 233 18 filings · 2021-08-20 → 2026-06-18

LOGISTICS DEVELOPMENT GROUP PLC

LDG
Industrial Goods and Services Share price 17.50p Market cap £72m Overall fit 300 /1000

Attractive discount to a conservatively-marked NAV with disciplined capital returns, but no material AI-receiver exposure and only modest look-through operating leverage — fails two of the investor's three core pillars.

Fair value range 20p–24p Mid case · £91m
Absolute upside +25.7% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Published quarterly NAV of 26.7p provides a clear anchor
  • Recent third-party validation of two largest positions (Alliance take-private, Finsbury refinancing)
  • Wide observable discount to NAV is arithmetic
Limits the call
  • Private valuations set by related-party DBAY create conflict
  • Rising WS Holdco concentration into an unproven logistics roll-up
Methodology

NAV-based sum-of-parts with investment-company discount

In one line · bull case

Deep discount to a conservatively marked NAV backed by third-party-validated private holdings, with a disciplined capital-return record.

In one line · biggest risk

DBAY-controlled valuations combined with growing WS Holdco concentration into an unproven UK logistics roll-up could erode both the NAV integrity and the realisation timing that support today's thesis.

Drivers
AI beneficiary 18 /100
Bakery, consumer healthcare distribution, IT services and UK ground logistics — no direct AI-buildout exposure and commodity IT services face displacement risk.
Operating leverage 25 /100
Holding-company vehicle over mostly asset-heavy or asset-light-distribution businesses; only SQLI shows software-style leverage and it's ~12% of NAV.
Earnings vs expectations 50 /100
Not enough guidance/consensus data to judge — 'not enough data' 50.
Growth momentum 40 /100
NAV/share flat at 26.7p across three consecutive quarters; underlying EBIT declined 21% y/y.
Moat 30 /100
Individual portfolio brands (Kelo-Cote, APC parcel network) have narrow niche positions but nothing structural at group level.
Earnings quality 50 /100
P&L is dominated by Level-3 fair-value gains — clean statutory measure but low cash conversion until realisation.
Management quality 65 /100
DBAY has credible mid-market PE record and strong capital-return discipline; related-party fee structure and repeated AGM rebellions on pre-emption offset.
Cyclicality 55 /100
Defensive bakery/consumer-health offset by rising exposure to cyclical UK logistics via WS Holdco.
Leverage 15 /100
Parent effectively net cash after Finsbury refinancing; asset-level debt at Alliance being materially paid down.
Value-trap signals · 4
  • Persistent >30% discount to published NAV despite active buybacks
  • Related-party fee structure with DBAY as both manager and NAV-setter
  • Shareholder rejection of pre-emption disapplication at both 2025 and 2026 AGMs indicates governance overhang
  • Parent cash depleted from £29.6m to £2.2m via reinvestment, reducing near-term buyback capacity

Logistics Development Group plc (LDG) — Research Note

Executive summary

LDG is an AIM-listed closed-end investing company managed by DBAY Advisors, holding minority/majority interests in four private businesses: Finsbury Food (UK specialty bakery), SQLI (European digital/e-commerce services), Alliance Pharma (consumer healthcare distribution) and WS Holdco (UK logistics buy-and-build). Across the five years of filings the vehicle transitioned from operating group (Eddie Stobart) into an investing company, distributed £27m+ to shareholders via buybacks/tenders, and quadrupled portfolio fair value to £107.8m (Dec-25), while trading persistently at a wide discount to NAV. The single most important valuation point today: unaudited NAV per share is 26.7p vs a 18.0p share price — a ~33% discount — with the underlying private assets held at 7.5× EV/EBITDA against typical comparable ranges of 10–15×.

Fair value estimate

  • Methodology: NAV-based sum-of-parts, applying a warranted discount for an AIM-listed closed-end investing entity with concentrated Level-3 private holdings.
  • Anchoring figures: last disclosed NAV = 26.7p (unchanged at 30 Jun-25, 30 Sep-25 and 31 Dec-25 2026-05-15 FY25); investments fair-valued at £107.8m; £11.4m cash returned from Finsbury refinancing post period-end further de-risked the largest single line.
  • Discount assumption: 10–25% investment-company discount is defensible given (i) NAV opacity (private valuations set by DBAY-linked funds), (ii) illiquid AIM float, offset against (iii) disciplined capital-return record and (iv) conservative held-at valuations.
  • Fair value range per share: 20p – 24p (NAV × 0.75 to 0.90).
  • Implied market cap: ~£83m – £99m (413.8m shares).
  • Upside to mid (22p) from 18p: +22%; low-end +11%, high-end +33%.

Sector context

  • ICB tag = Industrial Goods & Services, but functionally LDG is an investing/holding company, not an industrial. Nearest listed analogues on AIM/LSE are DBAY's sister vehicle assets and other AIM investment companies trading at NAV discounts (e.g. Marwyn Value Investors, Gresham House Strategic historically, Symphony International Holdings). Quality is above the AIM investing-company norm on capital discipline (regular tenders, published quarterly NAV) but below on liquidity and disclosure granularity.

Investment thesis (3 bullets)

  • Wide discount to a conservatively-marked NAV: Portfolio held at 7.5× EV/EBITDA vs 10–15× for public comparables and current price is a further 33% discount to that NAV — two layers of valuation cushion 2026-05-15 FY25.
  • Demonstrated capital-return discipline: £21m tender at 19p in April-25 plus prior buyback (£5.1m) and £27m aggregate distributions since 2020; Board has stated a formula of ~50% of net cash on future realisations returned to shareholders 2025-05-22 FY24; 2026-05-15 FY25.
  • De-risked balance sheet after Finsbury refinancing: £11.4m returned in Jan-26 reduced original Finsbury cost exposure from £14.2m to £2.8m while retaining the 25.3% equity stake, meaning capital has already been substantially recovered on the largest legacy position 2026-05-15 FY25 subsequent events.

Key risks (3 bullets)

  • Related-party governance concentration: DBAY is both investment manager and lead investor in every underlying holding, sets the fair values that flow into NAV, and receives performance fees (£4.35m accrued at Dec-25) payable on realisation — inherent conflict of interest 2026-05-15 FY25 note 14.
  • Post-Finsbury exit, WS Holdco becomes the dominant position (50.7% and rising), converting LDG's profile from diversified minority-stake vehicle into a concentrated bet on a UK logistics roll-up in a highly cyclical, low-margin end market 2026-03-17 WS acquisition; 2026-05-15 update.
  • Discount persistence risk: Shares have traded at a discount to NAV for the entire disclosed period despite buybacks and quarterly NAV publication; two consecutive AGMs (2025, 2026) rejected the pre-emption-disapplication special resolutions, signalling investor scepticism of management 2025-06-25 AGM; 2026-06-18 AGM.

Operating leverage

Not a natural fit for the operating-leverage lens because LDG itself is a holding company (four employees, £1.3m admin cost). At the underlying-portfolio level: SQLI is the only holding with meaningful software-style leverage — it grew revenue 2% to €252m while lifting margin 50bps to 10% in 2025, targeting a further 140bps expansion on 3% revenue growth in FY26 2026-05-15 FY25 IM report. Finsbury is a low-margin volume bakery (£445m rev, unspecified but historically mid-single-digit EBITDA%) with modest incremental margins. Alliance is asset-light (outsourced manufacturing) but is essentially a marketing/distribution engine — leverage comes from brand extension not capacity fill. WS Holdco is asset-heavy logistics — typically 3–5% EBIT margins, near-zero incremental leverage. Net: a 10–20% revenue surprise across the portfolio would probably lift group EBITDA 10–25%, not multiples. This is a valuation-discount story, not a fixed-cost-inflection story.

Value-trap signals

  • Persistent >30% NAV discount despite active buybacks — market is signalling scepticism about either NAV integrity or realisation timing.
  • Related-party fee structure and DBAY control of both LDG and the underlying assets could compress ultimate returns to minority holders.
  • Twice-rejected pre-emption-disapplication resolutions indicate an activist shareholder overhang.
  • Cash on parent balance sheet fell from £29.6m to £2.2m in 2025 (reinvested into WS Holdco) — reduces optionality for opportunistic buybacks near-term.

Earnings vs. expectations

Not meaningfully applicable — LDG is an investing company reporting fair-value gains, not a trading business with guidance. FY25 delivered underlying EBIT of £14.6m vs FY24's £18.4m (both principally investment revaluation gains), and NAV/share held flat at 26.7p through H2-25. No explicit management guidance nor sell-side consensus is referenced across the filings, so "beat/meet/miss" categorisation would be manufactured. Qualitatively, the two most material calls — the Alliance take-private premium (42% above prior-period valuation) and the Finsbury de-risking refinance — both crystallised value above carrying value, so on realisation basis management has slightly over-delivered.

Conviction

3 — moderate. Anchoring factors: (1) NAV is regularly published and audited by Haysmac; (2) two large positions have recent third-party price validation (Alliance take-private at 64.75p, Finsbury refinancing cash-out); (3) discount to NAV is arithmetic and easily observable. Limiting factors: (1) NAV depends on DBAY-set private valuations with clear related-party incentive; (2) forward earnings power now hinges heavily on WS Holdco execution, which has no established track record.

Driver scoring

  • ai_beneficiary (18): Portfolio is bakery, consumer healthcare distribution, mid-market IT services, and UK ground logistics. SQLI uses AI internally to drive developer efficiency 2026-05-15 FY25 — this is a light positive but not a receiver-of-AI-capex story; commodity IT services are structurally at risk from AI displacement.
  • operating_leverage (25): Look-through mix is dominated by low-fixed-cost businesses; SQLI provides some leverage but is only ~12% of NAV.
  • earnings_surprise_trend (50): Insufficient guidance/consensus data to judge; NAV realisations (Alliance) have modestly exceeded carrying value — flat-neutral.
  • cyclicality (55): Bakery/consumer health defensive; logistics moderately cyclical; the growing WS Holdco weighting increases cyclicality of the vehicle.
  • moat (30): Individual assets have decent niche positions (Kelo-Cote in scar care, WS parcel network) but nothing structural or durable at the group level.
  • leverage (15): Parent net cash after Finsbury refinancing; Alliance had £275m net debt but that's asset-level and is being paid down to ~£175m post disposal.
  • earnings_quality (50): Reported profit is entirely fair-value gains on Level-3 private holdings — clean vs statutory measure, but low cash-conversion until realisations occur.
  • management_quality (65): DBAY has a credible mid-market PE track record; capital-return discipline is unusually good for AIM. Offset by related-party structure and shareholder rebellions on pre-emption votes.
  • growth_momentum (40): NAV flat over the last three quarterly readings at 26.7p; underlying EBIT down y/y (£18.4m → £14.6m).

Overall score: 300 / 1000

LDG is a valuation-discipline and downside-protection story with essentially no AI-receiver angle and limited operating leverage — the first two of the investor's three pillars are weak. It could reasonably outperform on NAV closure alone, but it does not participate in the AI cycle in any material way and would not benefit from an AI-driven revenue upside surprise. It scores partial credit on valuation and quality, and falls squarely in the "low fit / worth knowing about" band.

Filings consulted · 23

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-06-18Result OF Agm2026-06-18_9625961_result-of-agm.md0.30
  2. 2026-05-20Posting OF Annual Report And Notice OF Agm2026-05-20_9576464_posting-of-annual-report-and-notice-of-agm.md0.95
  3. 2026-05-15Portfolio Company Update Acquisition2026-05-15_9571478_portfolio-company-update-acquisition.md0.75
  4. 2026-05-15Final Results For The Year Ended 31 December 20252026-05-15_9569664_final-results-for-the-year-ended-31-december-2025.md1.00
  5. 2026-03-17Portfolio Company Update Acquisition2026-03-17_9478279_portfolio-company-update-acquisition.md0.75
  6. 2025-09-25Interim Results For Six Months Ended 30 June 20252025-09-25_9130142_interim-results-for-six-months-ended-30-june-2025.md0.77
  7. 2025-06-25Result OF Agm2025-06-25_8947907_result-of-agm.md0.20
  8. 2025-05-28Posting OF Annual Report And Notice OF Agm2025-05-28_8899301_posting-of-annual-report-and-notice-of-agm.md0.62
  9. 2025-05-22Final Results For The 13 Months TO 31 Dec 20242025-05-22_8891199_final-results-for-the-13-months-to-31-dec-2024.md0.65
  10. 2025-01-10Recommended Acquisition OF Alliance Pharma Plc2025-01-10_8657392_recommended-acquisition-of-alliance-pharma-plc.md0.49
  11. 2024-08-23Interim Results For Six Months Ended 31 May 20242024-08-23_8381077_interim-results-for-six-months-ended-31-may-2024.md0.41
  12. 2024-05-09Result OF Agm2024-05-09_8185929_result-of-agm.md0.14
  13. 2024-04-02Posting OF Annual Report And Notice OF Agm2024-04-02_8116432_posting-of-annual-report-and-notice-of-agm.md0.43
  14. 2024-03-27Final Results For Year Ended 30 November 20232024-03-27_8108531_final-results-for-year-ended-30-november-2023.md0.45
  15. 2023-08-31Interim Results For Six Months Ended 31 May 20232023-08-31_7728478_interim-results-for-six-months-ended-31-may-2023.md0.41
  16. 2023-05-03Result OF Agm2023-05-03_7511243_result-of-agm.md0.07
  17. 2023-04-04Posting OF Annual Report And Notice OF Agm2023-04-04_7426639_posting-of-annual-report-and-notice-of-agm.md0.24
  18. 2023-03-31Final Results For Year Ended 30 November 20222023-03-31_7380083_final-results-for-year-ended-30-november-2022.md0.25
  19. 2022-08-26Interim Results For Six Months Ended 31 May 20222022-08-26_7102593_interim-results-for-six-months-ended-31-may-2022.md0.23
  20. 2022-05-12Result OF Agm2022-05-12_6840456_result-of-agm.md0.07
  21. 2022-04-14Posting OF Annual Report Amp Notice OF Agm2022-04-14_6945819_posting-of-annual-report-amp-notice-of-agm.md0.24
  22. 2022-04-06Final Results2022-04-06_6862212_final-results.md0.25
  23. 2021-08-20Interim Results For Six Months Ended 31 May 20212021-08-20_6600689_interim-results-for-six-months-ended-31-may-2021.md0.09

This research note was authored by a large language model after reading 18 regulatory filings published between 2021-08-20 and 2026-06-18. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.